| First Author | Zong J | Year | 2013 |
| Journal | Lab Invest | Volume | 93 |
| Issue | 10 | Pages | 1128-36 |
| PubMed ID | 23958879 | Mgi Jnum | J:200979 |
| Mgi Id | MGI:5510604 | Doi | 10.1038/labinvest.2013.99 |
| Citation | Zong J, et al. (2013) NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload. Lab Invest 93(10):1128-36 |
| abstractText | Nucleotide-binding oligomerization domain-2 (NOD2, also designated CARD15), a member of the NOD-leucine-rich repeat (LRR) protein family (also called the CATERPILLAR family), is upregulated in atheroma lesions and has an important role in regulating the intracellular recognition of bacterial components by immune cells. However, the effect of NOD2 on cardiac hypertrophy induced by a pathological stimulus has not been determined. Here, we investigated the effects of NOD2 deficiency on cardiac hypertrophy induced by aortic banding (AB) in mice. Cardiac hypertrophy was evaluated by echocardiographic, hemodynamic, pathological, and molecular analyses. NOD2 expression was upregulated in cardiomyocytes after aortic banding surgery in wild-type (WT) mice. NOD2 deficiency promoted cardiac hypertrophy and fibrosis 4 weeks after AB. Further, the enhanced activation of TLR4 and the MAPKs, NF-kappaB and TGF-beta/Smad pathways were found in NOD2-knockout (KO) mice compared with WT mice. Our results suggest that NOD2 attenuates cardiac hypertrophy and fibrosis via regulation of multiple pathways. |
